Glass House Brands Inc.

GLAS Healthcare Drug Manufacturers Specialty & Generic

Glass House Brands Inc.’s revenue for fiscal 2025 (year ended December 2025) was $182.0 million, down 9.41% from fiscal 2024.

Revenue
−1.24%
EPS
−320.0%
Free cash flow
−123.4%
Total debt
−17.2%

Quarter to June 2026, against a year earlier

2.04 0.19 −8.52%
Market cap
$172.7M
P/E
0.0×
Fwd P/E
−5.6×
Dividend yield
—
F-score
3/9
Altman Z
1.38
Beneish M
−3.38
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+7 more quarters

0.00 0.00 0.00 0.00
P/S ratio
3.37 3.98 4.00 6.52
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(122.60) (195.93) (60.48) 6,446.33
P/B ratio
6.95 8.83 8.37 15.89
Price to Tangible BV
8.01 8.92 9.70 16.09
EV/Sales
3.61 4.30 4.25 6.73
EV/EBITDA
49.28 0.00 0.00 0.00
EV/Operating CF
28.46 68.29 (271.76) (58.57)
EV/FCF
(166.08) (50.40) (28.41) (32.37)
Quick Ratio
1.03 0.46 0.79 0.55
Current Ratio
2.24 1.78 1.85 1.33
Net Debt/EBITDA
(5.93) (6.83) (4.29) 46.53
Debt/Assets
21.91% 21.69% 21.12% 17.78%
Debt/Equity
0.79 0.84 0.81 0.77
Asset Turnover
0.59 0.58 0.56 0.55
Operating CF/Net income
0.33 0.20 0.59 (0.02)
Capex/Depreciation
(2.16) (0.54) (0.88) (0.56)
Interest Coverage
(6.26) (11.40) (11.08) (4.77)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
43.25% 46.76% 43.14% 29.23%
Intangible Assets out of Total Assets
0.04 0.00 0.04 0.00
Share Based Compensation of Revenue
10.61% 8.36% 11.16% 8.96%
Graham Net Nets
(0.25) (0.23) (0.23) (0.15)
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(2.93%) (6.21%) (7.35%) (5.85%)
Free Cash Flow Yield
(0.64%) (2.14%) (3.74%) (3.19%)
Revenue per Share
0.47 0.62 0.47 0.53
Operating CF per Share
(0.06) (0.05) (0.13) 0.00
Capex per Share
(0.10) (0.03) (0.04) (0.02)
Free Cash Flow per Share
(0.17) (0.07) (0.18) (0.02)
Cash per Share
0.32 0.15 0.28 0.21
Shareholders Equity per Share
1.08 1.00 0.98 0.82
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
1.08 1.00 0.98 0.82
Free Cash Flow
(13.69) (5.88) (15.30) (1.93)
Working Capital
41.11 29.79 34.15 17.85
Capital Expenditures
(8.63) (2.18) (3.55) (2.11)
Net Current Asset Value
(156.22) (168.71) (166.05) (169.53)
EV/EBIT
0.00 0.00 0.00 0.00
Capex to Sales
0.22 0.04 0.09 0.04
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
5.99 6.17 7.92 10.80
Average Payables
27.85 29.69 34.39 37.79
Average Inventory
14.11 19.28 23.61 26.85
Average Assets
311.80 314.53 318.47 323.97
Average Common Equity
78.17 79.90 85.25 86.58

Fold the line items

Columns are period end dates · fundamentals updated 2 Nov 2026